A Mathematical Model for Apoptosome Assembly: The Optimal Cytochrome c/Apaf-1 Ratio by Nakabayashi, J. & Sasaki, A.
A Mathematical Model for 
Apoptosome Assembly: The 
Optimal Cytochrome c/Apaf-1 Ratio
Nakabayashi, J. and Sasaki, A.
IIASA Interim Report
December 2006
 
Nakabayashi, J. and Sasaki, A. (2006) A Mathematical Model for Apoptosome Assembly: The Optimal Cytochrome c/Apaf-1 
Ratio. IIASA Interim Report. Copyright © 2006 by the author(s). http://pure.iiasa.ac.at/8022/ 
Interim Report on work of the International Institute for Applied Systems Analysis receive only limited review. Views or 
opinions expressed herein do not necessarily represent those of the Institute, its National Member Organizations, or other 
organizations supporting the work. All rights reserved. Permission to make digital or hard copies of all or part of this work 
for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial 
advantage. All copies must bear this notice and the full citation on the first page. For other purposes, to republish, to post on 
servers or to redistribute to lists, permission must be sought by contacting repository@iiasa.ac.at 
  
 
International Institute for 
Applied Systems Analysis 
Schlossplatz 1 
A-2361 Laxenburg, Austria 
Tel: +43 2236 807 342
Fax: +43 2236 71313
E-mail: publications@iiasa.ac.at
Web: www.iiasa.ac.at
 
Interim Reports on work of the International Institute for Applied Systems Analysis receive only
limited review. Views or opinions expressed herein do not necessarily represent those of the
Institute, its National Member Organizations, or other organizations supporting the work. 
Interim Report IR-06-077
A mathematical model for apoptosome assembly: 
The optimal cytochrome c/Apaf-1 ratio 
Jun Nakabayashi (nakabaya@bio-math10.biology.kyushu-ac.jp) 
Akira Sasaki (asasascb@mbox.nc.kyushu-u.ac.jp) 
 
 
Approved by 
Ulf Dieckmann 
Program Leader, Evolution and Ecology Program 
December 2006 
 
 
  
Contents 
Abstract............................................................................................................................. 2 
1 Introduction ................................................................................................................... 3 
2 A model for Apaf-1 heptamer assembly........................................................................ 5 
3 The equilibrium concentrations of intermediate and final oligomers............................ 9 
4 Transient behavior and finite time optimization.......................................................... 11 
5 Tetamer is the most efficient in conversion ratio ........................................................ 12 
6 Effect of dissociation ................................................................................................... 13 
7 Discussion.................................................................................................................... 13 
References ...................................................................................................................... 16 
Figures ............................................................................................................................ 19 
A mathematical model for apoptosome assembly: The optimal  
Cytochrome c/Apaf-1 ratio. 
Jun Nakabayashi¹ and Akira Sasaki¹ ² 
¹ Department of Biology, Faculty of Sciences, 
Kyushu University, Fukuoka 812-8581, Japan 
Phone:+81-92-642-2641 Facsimile:+81-92-642-2645  
Email:nakabaya@bio-math10.biology.kyushu-u.ac.jp 
² Evolution and Ecology Program, 
International Institute for Applied Systems Analysis, 
2361 Laxenburg, Austria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Abstract
Apoptosis, a highly conserved form of cell suicide, is regulated by apoptotic signals and their trans-
duction with caspases, a family of cystein proteases. Caspases are constantly expressed in the
normal cells as inactive pro-enzymes. The activity of caspase is regulated by the proteolysis. Se-
quential proteolytic reactions of caspases are needed to execute apoptosis. Mitochondrial pathway
is one of these apoptotic signal pathways, in which caspases are oligomerized into characteristic
heptamer structure, called apoptosome, with caspase-9 that activate the effector caspases for apop-
tosis. To investigate the dynamics of signal transduction pathway regulated by oligomerization, we
construct a mathematical model for Apaf-1 heptamer assembly process. The model first reveals
that intermediate products can remain unconverted even after all assemble reactions are completed.
The second result of the model is that the conversion efficiency of Apaf-1 heptamer assembly is
maximized when the initial concentration of cytochrome c is equal to that of Apaf-1. When the
concentration of cytochrome c is sufficiently larger or smaller than that of Apaf-1, the final Apaf-1
heptamer production is decreased, because intermediate Apaf-1 oligomers (tetramers and bigger
oligomers), which themselves are unable to form active heptamer, accumulate too fast in the cells,
choking a smooth production of Apaf-1 heptamer. Slow activation of Apaf-1 monomers and small
oligomers increase the conversion efficiency. We also study the optimal number of subunits com-
prising an active oligomer that maximize the conversion efficiency in assembly process, and found
that the tetramer is the optimum.
Keywords: apoptosis, apoptosome, mitochondrial pathway, cytochrome c, Apaf-1, oligomerization
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1 Introduction
Apoptosis is a highly conserved form of cell suicide, which plays a key role in controlling the cell
number in multicellular organisms(Zimmermann et al., 2001). The apoptotic signals are transduced
through the specific pathways. All of the apoptotic signal pathways are composed of the cascade
of caspase reactions. Caspases are highly conserved cystein protease(Nunez et al., 1998) that are
found in variety of multicellular organisms. In human, 14 caspases are identified. Caspases play
critical roles in regulating apoptosis and inflammation of cells, and are constantly expressed in
normal cells as inactive pro-enzymes. The activity of caspases is strictly regulated by the protein
cleavage. Once caspase is cleaved into subunits, an active complex is produced from the large and
the small subunits. The active complex of caspase can cleave the specific site of caspase and/or
substrates in the downstream of the cascade. The apoptotic signal is transduced by this sequential
activations of caspases. Caspases are divided into two classes by their functions in this cascade.
One, called initiator caspase, takes part in the upstream of the cascade, which are activated by the
receptor of the apoptotic signal and/or the abnormality of the cells such as DNA damages. The
other, called effector caspase, takes part in the downstream of the cascade, which is cleaved and
activated by the initiators. Effector caspases can cleave and activate many other substrates that
mediate the apoptosis.
There are two major pathways of apoptosis – extrinsic triggering (“death receptor medi-
ated) pathways and intrinsic triggering (by stress, chemotherapeutics, and UV irradiation) path-
ways(Scaffidi et al., 1998). In the receptor mediated pathway, the ligands such as tumor necrosis
factor bind to the specific “death receptor, initiating the apoptosis of the cell as extrinsic stimuli.
These receptors are characterized by the conserved cytoplasmic sequence called the death domain.
The ligand and receptor complex can bind to caspase-8 through the adaptor molecule FADD. FADD
links between the ligand/receptor complex and caspase-8. Caspase-8 recruited by the FADD is ac-
tivated by auto cleavage. Activated caspase-8 can cleave and activate the effector caspase-3 and/or
3
-7 directly.
The intrinsic stimuli such as stress, chemotherapeutics and UV irradiation induces the
release of cytochrome c from the mitochondria, which activates Apaf-1. In the present paper, we
focus on the process of the activation of Apaf-1 monomers and their assembly to heptamers in the
intrinsic triggering pathway of apoptosis.
Either Bid truncation by active caspase-8 or the abnormality of cells triggers the release
of the cytochrome c from mitochondria to cytoplasm(Jiang & Wang, 2004; Sprick & Walczak,
2004). The released cytochrome c activates the Apaf-1 (Apoptotic Protease Activating Factor-1)
by introducing the conformational change of Apaf-1. Activated Apaf-1 monomers then interact with
each other to form Apaf-1 oligomers. This oligomerization of Apaf-1 monomers , and subsequent
oligomerization of intermediate Apaf-1 oligomers, finally gives rise to a 700kDa large protein
complex called apoptosome(Cain et al., 1999; Zou et al., 1999; Saleh et al., 1999; Cain et al.,
2000; Adams & Cory, 2002; Cain et al., 2002). Caspase-9 is activated without cleaving them
in apoptosome. Unlike other caspases, the activity of caspase-9 is regulated, not by its cleavage
by upstream caspases, but by the apoptosome produced through the oligomerization of activated
Apaf-1’s. The schematic illustration of mitochondrial pathway is shown in Fig. 1. The alteration
of the factors regulating the apoptosome assembly contribute to pathogenesis of the cancer(Hajra
& Liu, 2004). Apoptosome acts as an executioner of the apoptosis.
Cells are divided into two classes by their choice of the primary apoptotic pathways(Scaffidi
et al., 1999). Type I cells are characterized by their greater amount of death-inducing signaling
complex (DISC), which is composed of death receptor and adapter protein FADD, than type II cells.
In type I cells, caspase-8 is recruited and activated by the DISC within seconds and is caspase-3 in
30 minutes. Whereas, in type II cells, the recruitment of FADD and caspase-8 by death receptor
is strongly suppressed. Caspase-3 are primarily activated by caspase-9 through the mitochondrial
pathway in type II cells. The activation of caspase-8 and caspase-3 takes 60 minutes in type II
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cell. Because apoptosome is a large protein complex which are formed through complex protein
interactions, it is difficult to investigate the dynamics of the apoptosome assembly experimentally.
It is not yet clear how the activated Apaf-1 oligomers interact with each other to make Apaf-1
heptamer. We therefore highlight the process of Apaf-1 heptamer assembly by using a simple
mathematical model.
Previous mathematical models on the apoptotic signal transduction proposed so far(Fussenegger
et al., 2000; Bentele et al., 2004) have handled the process of apoptosome assembly as a single non-
linear reaction term, where complex interactions between oligomers (from monomer to heptamer)
are embedded into a nonlinearity parameter. It is important, however, to develop a model for
the oligomerization of Apaf-1 itself, because the accuracy and swiftness of apoptosis critically de-
pends on how efficient and quickly the Apaf-1 heptamer is assembled. We here construct a simple
mathematical model of Apaf-1 heptamer assembly, and study how the oligomerization process of
Apaf-1’s is adjusted for an efficient regulation of the activity of caspase-9, the key molecule that
finally switches on the apoptotic reaction.
2 A model for Apaf-1 heptamer assembly
We here consider the formation of large protein complexes that are produced by the pairwise as-
sembly among two or more kinds of unit proteins. We focus on the oligomerization of Apaf-1, but
the result would be applicable for other system with similar assembly process. We first consider
the activation of Apaf-1 monomer. Cytochrome c in the cytoplasm binds to an inactive Apaf-1 and
changes its conformation(Acehan et al., 2002). Apaf-1 is 130kDa protein that contains two WD-
40 repeats in the C-terminal side and CARD (CAspase Recruitment Domain) in the N-terminal
side(Vaughn et al., 1999). In inactive Apaf-1, CARD domain binds WD-40 repeat of Apaf-1.
Cytochrome c interacts with Apaf-1 through the WD-40 repeats. The Apaf-1 then changes its
conformation by extending its CARD domain towards outside. Activated Apaf-1 with extended
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CARD domain can interact with each other through its CARD domain(Shiozaki et al., 2002). We
assume that cytochrome c is released from mitochondria within a sufficiently short time. The re-
lease of cytochrome c is triggered by the abnormality of cells, and regulated by caspase-8 which
is initiator of apoptotic signal transduction. By denoting by α the association constant for the
binding of cytochrome to Apaf-1, the reaction formula is
cytochrome c+ inactive Apaf-1
α
→ active Apaf-1
We denote the concentration of cytochrome c and inactive Apaf-1 by c and y, respectively.
The time change of cytochrome c and inactive Apaf-1 concentrations is then given by
dc
dt
=
dy
dt
= −αyc (1)
The activated Apaf-1 can interact with each other with association rate β. The 3-D structure of
apoptosome(Acehan et al., 2002) is revealed that apoptosome is composed of 7 Apaf-1 molecules.
We consider the assembly of two Apaf-1 oligomers for the mathematical simplicity, one with i Apaf-
1 molecules and another with j molecules, giving rise to a larger oligomer composed of i+j Apaf-1’s,
but only when i + j is less than 7. An intermediate oligomer dissociates into smaller oligomers
again with the dissociation constant γ. The diagram of oligomerization is shown in Fig. 2. The
reaction formula for this is
oligomeri + oligomerj
β
−−→
←−−γ
oligomeri+j (2)
The concentration of Apaf-1 oligomer composed of i molecules of Apaf-1 is designated by
xi. The time change of the concentration of each oligomer is given from both the term of the
production and the consumption. The active Apaf-1 monomer is produced from inactive Apaf-1
and can interact with oligomers composed of 1 to 6 Apaf-1 molecules. The time change of Apaf-1
6
active monomer is then given as
dx1
dt
= αyc− βx1(2x1 + x2 + x3 + x4 + x5 + x6) + γ(2x2 + x3 + x4 + x5 + x6 + x7)
dx2
dt
= βx21 − βx2(x1 + 2x2 + x3 + x4 + x5) + γ(x3 + 2x4 + x5 + x6 + x7)− γx2
dx3
dt
= βx1x2 − βx3(x1 + x2 + 2x3 + x4) + γ(x4 + x5 + 2x6 + x7)− γx3
dx4
dt
= β(x1x3 + x
2
2)− βx4(x1 + x2 + x3) + γ(x5 + x6 + x7)− 2γx4
dx5
dt
= β(x1x4 + x2x3)− βx5(x1 + x2) + γ(x6 + x7)− 2γx5
dx6
dt
= β(x1x5 + x2x4 + x
2
3)− βx6x1 + γx7 − 3γx6
dx7
dt
= β(x1x6 + x2x5 + x3x4)− 3γx7 (3)
Note that though we have modeled the dissociation process as the reverse reaction of the
association of two molecules (see (2)), there might be other ways to formulate dissociation (e.g.
collapse of a n-mer into n monomers at once). There seems to be no empirical evidence for or
against our assumption in dissociation process.
Though actual apoptosomes are composed of 7 Apaf-1 molecules, the model can be expanded
to the cases where the final product is composed of n molecules. Active monomer can then be
assembled with oligomers composed of 1 to n− 1 molecules. Likewise the oligomer composed of i
molecules can be assembled with oligomers composed of j molecules, (but only when i + j is less
than n). For mathematical simplicity, we first examined the Apaf-1 heptamer assembly without
any dissociation reaction (γ = 0). We then examined the effect of the positive dissociation constant
later. Throughout the paper, we used the reported association constant of interaction between
cytochrome c and Apaf-1: α = 0.004 (µM−1s−1)(Purring-Koch & McLendon, 2000). The time
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change of the concentration of each oligomers is then given as
dx1
dt
= αyc− βx1
n−1∑
j=1
(1 + δ1j)xj
dxi
dt
= β
[i/2]∑
k=1
xkxi−k − βxi
n−i∑
j=1
(1 + δij)xj (4)
dxn
dt
= β
[n/2]∑
k=1
xkxn−k
where [n/2] denotes the largest integer which is less than or equal to n/2, and δij = 1 if i = j and
δij = 0 if i 6= j. The initial concentration of cytochrome c and Apaf-1 is denoted by c0 and y0,
respectively. Other initial densities are assumed to be zero: xi(0) = 0, (i = 1, 2, · · · , n).
To non-dimensionalize the equations (4) with γ = 0, we denote the concentration xi(t), y(t)
and c(t) relative to that y0 of the initial inactive Apaf-1 by Xi(t) = xi(t)/y0, Y (t) = y(t)/y0 and
C = c(t)/y0, respectively. Next we rescale time as τ = αy0t. The model (1) and (4) in terms of Xi,
Y , C and τ are expressed as
dC
dτ
=
dY
dτ
= −Y C
dX1
dτ
= Y C − λX1(2X1 +X2 + · · ·+Xn−1)
dXi
dτ
= λ


[i/2]∑
k=1
XkXi−k −Xi
n−i∑
j=1
(1 + δij)Xj

 (5)
dXn
dτ
= λ
[n/2]∑
k=1
XkXn−k
where λ = β/α. The initial conditions are Xi(0) = 0, (i = 1, 2, · · · , n), Y (0) = 1, and C(0) = C0 =
c0/y0. There are only two parameters, λ and C0 in the rescaled dynamics. An example of the time
course of the concentration of each oligomer is shown in Fig. 3.
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3 The equilibrium concentrations of intermediate and final oligomers
Now we consider the ratio of the equilibrium concentration of the final product to that of initial
inactive Apaf-1. Because it is reported that the stoichiometry of Apaf-1 to procaspase-9 is 1:1,
7 molecules of caspase-9 are required to saturate binding sites on the apoptosome composed of 7
Apaf-1 molecules. The local high concentration of procaspase-9 in apoptosome may facilitate to
form active dimer of caspase-9. It is very important to examine the number of Apaf-1 molecules
contained in final product of apoptosome assembly. When the concentration of the final product
becomes 1/7 of inactive Apaf-1, the efficiency of the conversion of the Apaf-1 heptamer assembly
becomes 100%. We define the conversion efficiency as the ratio of the equilibrium concentration
xn(∞) of the final product to 1/n of the initial concentration y0 of inactive Apaf-1: i.e. nXn(∞).
We first focus on the equilibrium after a sufficiently long time has passed since the introduction of
the apoptotic signal. As shown in section 6, the result without dissociation when sufficiently long
time has passed (large a t) compatible with the result with dissociation when γ is sufficiently small.
Because cytochrome c and inactive Apaf-1 is only consumed by the interaction with each other,
Yˆ Cˆ = 0. From the equilibrium condition for the time change of active monomer is described as
concentration
Xˆ1(2Xˆ1 + · · ·+ Xˆn−1) = 0,
we immediately have Xˆ1 = 0. Similarly, from the equilibrium condition for Xˆi, we have
[i/2]∑
k=1
XˆkXˆi−k − Xˆi
n−i∑
j=1
(1 + δij)Xˆj = 0.
Suppose now that Xˆ1 = Xˆ2 = · · · = Xˆi−1 = 0. It then follows that, if i 6 [n/2] ,
[i/2]∑
k=1
XˆkXˆi−k − Xˆi
n−i∑
j=1
(1 + δij)Xˆj = −Xˆ
2
i − Xˆi
n−i∑
j=i+1
Xˆj = 0, (6)
and hence Xˆi = 0. However, if i > [n/2], the left hand side of (6) vanishes for arbitrary Xˆi > 0,
and hence the concentration of i-mer can remain positive at equilibrium if i > [n/2] (if i > 4 in the
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case of apoptosome with n = 7). Thus we conclude that
Xˆi = 0, for i = 1, 2, · · · , [n/2]
Xˆi > 0, for i = [n/2] + 1, [n/2] + 2, · · · , n (7)
This result indicates that the concentrations of intermediate oligomers, composed of less than the
half of n molecules are completely consumed in the cell at equilibrium, but a certain amount of
the intermediate oligomers consisting of more than half of n molecules remain unconverted at a
certain level at equilibrium. Thus the efficiency of Apaf-1 heptamer assembly cannot reach 100% if
n is greater than 3. The question then arises under what parameters, λ, C0, and n, the efficiency
of signal transduction is maximized, or, what parameters minimize the concentration of garbage
intermediate oligomers that fail to be converted to active final product.
We first examine how the conversion efficiency Xn/(1/n) = nXn changes by changing the
parameters C0 = c0/y0, the ratio of the initial concentrations of cytochrome c to inactive Apaf-1.
The effect of changing the initial concentration of cytochrome c on the time course of intermediate
and the final assembled oligomers are shown in Fig. 3. The equilibrium concentration of X7 is
plotted against the initial concentration of cytochrome c in Fig. 4. While the initial concentration
of cytochrome c is smaller than that of inactive Apaf-1, the final concentration of complete product
increases approximately linearly with the initial concentration of cytochrome c. The conversion
ratio nXn, the equilibrium concentration of complete assembly relative to the one n-th of that of
the initial inactive monomers, attains its maximum when the initial concentration of cytochrome c
is equal to that of Apaf-1. When the initial concentration of cytochrome c is further increased, the
final concentration of complete product start decreasing. For the sufficiently large initial amount of
cytochrome c, the final concentration of complete product can become less than 50% of its potential
maximum amount.
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4 Transient behavior and finite time optimization
The speed of the production of intermediate Apaf-1 oligomers would affect the final concentration
of the complete assembly. If Apaf-1 oligomers are slowly supplied, so monomers are produced
first, and then are dimers, trimers and so on, every intermediate oligomers have a higher chance of
contributing to the formation a complete assembly, than when all sizes of oligomers are produced at
once. Because the rate of changes of cytochrome c and inactive Apaf-1 are the same, the difference
between cytochrome c and inactive Apaf-1 is kept constant. If c0 > y0, therefore,
dy
dt
= −α(c0 − y0 + y)y
and
y(t) =
y0(c0 − y0)
c0
1
eα(c0−y0)t − y0c0
∼ const.× e−α(c0−y0)t (8)
If c0 = y0, on the other hand
dy
dt
= −αy2
and
y(t) =
1
1
y0
+ αt
∼ const.× t−1 (9)
Thus, if the initial concentration of cytochrome c is the same or close to that of inactive Apaf-1,
the inactive Apaf-1 decreases only geometrically slowly. However, if they are different, the inactive
Apaf-1 decreases exponentially fast (Fig. 5).
We denote by T50 the time until the concentration of the complete Apaf-1 heptamer reaches
50% of the final concentration. The parameter dependence of T50 is summarized in Fig. 6. In the
case of n = 7, T50 monotonically decreases with c0/y0 in almost all range of c0/y0 except when it is
very close to 1. The speed of the Apaf-1 activation is thus accelerated by increasing the amount of
cytochrome c release. When c0 = y0, however, Apaf-1 is slowly activated as described previously,
giving rise to a local peak of T50 around c0 = y0.
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Though the conversion efficiency at equilibrium is maximized at c0/y0 = 1, the time required
for the accumulation of the final product becomes longer as c0/y0 approaches 1 (Fig. 6.) To
examine the conversion efficiency in biologically plausible time scale, we therefore consider the
concentration of complete Apaf-1 heptamer after a certain fixed time has passed. As shown in
Fig 7, the concentration of complete Apaf-1 heptamer at a prefixed time becomes high when c0/y0
is large and α/β is small. There is a certain optimal c0/y0 for a given fixed α/β. Thus, if α/β
is sufficiently small, the optimal c0/y0 ratio can be far larger than 1. This is quite different from
the conversion ratio at equilibrium ( Fig 8). The area for high concentration of complete Apaf-1
heptamer is restricted in the region near c0/y0 = 1.0.
5 Tetramer is the most efficient in conversion ratio
At equilibrium after sufficiently long time has passed, the concentration of complete Apaf-1 hep-
tamer for fixed α/β is maximized when c0/y0 = 1.0, because Apaf-1 activation proceed geomet-
rically slowly when c0/y0 = 1.0 as mentioned previously. The equilibrium concentration of the
complete assembly changes also with the number of molecules n that comprises the final assembly,
as shown in Fig. 4. This result shows that the tetramer (n = 4) is the most efficient complex for
the conversion independent of the initial concentration of cytochrome c. The conversion ratio does
not related to biological function. The reason why the actual apoptosome is composed of heptamer
cannot be explained by the conversion ratio. It is necessary to consider other reasons why hep-
tamer is adopted with the actual apoptosome. If the conversion ratio of signal to final product is
to be maximized, the tetramer is the most efficient among oligomers more than two units. In this
respect, the fact that Apaf-1 heptamer, rather than tetramer, is used is not understood only from
the optimization of the conversion ratio. The reason why organism uses heptamers might there-
fore be explained by other hypothesis such as improved tolerance to noise by virtue of a greater
nonlinearity of response to signal by using oligomers.
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6 Effect of dissociation
Here we consider the dissociation of Apaf-1 oligomers by restoring a positive γ in (3). Though Apaf-
1 heptamer can be dissociated into smaller oligomers, an introduction of dissociation increases the
final concentration of Apaf-1 heptamer. This is because once produced intermediate oligomers can
be reconverted into smaller oligomers that contribute to further production of heptamers. Fig 9
illustrate this point. The equilibrium concentration is maximized at an intermediate γ, because
high concentration of heptamer cannot be maintained with too large dissociation rate.
As shown in Fig 9, when the dissociation constant is sufficiently small, the concentration
of complete Apaf-1 heptamer reaches a plateau at a low level that corresponds to the equilibrium
concentration of (4) that ignores dissociation (compare the trajectories for γ = 0 and γ = 10−4 in
Fig. 9). More specifically, this is expected if 1/γ is sufficiently smaller than the T50 for γ = 0, the
time until the concentration of the final product reaches half of its equilibrium level.
Therefore, if 1/γ is much longer than biologically interesting time scale, the results we
obtained in the previous sections by ignoring dissociation process can well approximate the behavior
of full kinetics.
7 Discussion
We construct a simple mathematical model for the Apaf-1 heptamer assembly process. We have
analytically shown, as in Eq. (7) in the text, that the substantial amount of intermediate oligomers
can remain at quasi-equilibrium before the dissociation of oligomers begins. The intermediate
oligomers composed of 6, instead of 7, Apaf-1 molecules are indeed found in in vitro assembly of
apoptosome(Acehan et al., 2002). Our model predicts that tetramers, pentamers, and hexamers
remain at equilibrium, and that among them hexamers are the most abundant (see Fig. 3). Though
we focussed on the Apaf-1 heptamer assembly with n = 7 unit proteins, our model can be applied
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to the assembly process with arbitrary number of unit proteins. Our model then reveals that a large
protein complex composed of, and assembled from, greater than 3 unit proteins is disadvantageous
in terms of the conversion efficiency in the signal transduction, because the amount of unconverted
intermediate oligomers increases with the number of unit proteins n if n > 3. As shown in Fig. 4, if
the others are the same, n = 4 (tetramer) is the optimum number of unit molecules that compose
of complete assembly, which minimizes the amount of unconverted intermediate proteins. The
conversion efficiency Apaf-1 heptamer formation (nXn) also changes with the other parameters than
n. Our non-dimensionalized model (5) reveals that the concentration of each oligomer depends on
the two parameters, the concentration of released cytochrome c relative to the initial inactive Apaf-
1 concentration (c0/y0), and the ratio of the association rate of inactive Apaf-1 and cytochrome c
relative to the association rate of oligomerization of active Apaf-1 oligomers (α/β), in the following
ways.
If we focus on the equilibrium conversion ratio of Apaf-1 monomers to Apaf-1 heptamers,
we see from Fig. 8 that the region for high conversion efficiency is restricted in the region near
c0/y0 = 1.0. The conversion efficiency in in vitro Apaf-1 heptamer assembly experiment is found to
be close to 1 (Acehan et al., 2002), and, in the experiment, the molar ratio of Apaf-1 to cytochrome
c was indeed adjusted from 1:1 to 1:2.
Once triggered, all cytochrome c’s stored in mitochondria are released, regardless of the
duration and the strength of stimulus of the apoptotic signal (Goldstein et al., 2000). The ratio
c0/y0 in our model might therefore be much larger than 1 in the cells that undergo apoptosis through
mitochondrial pathway. We have shown in Fig 7 that the concentration of Apaf-1 heptamers that
is produced within a finite time since the cell received the signal is maximized at c0/y0 larger
than 1 when α/β, the ratio of the activation rate of monomers to the association constant for
oligomerization, is small. Though slow supply of the active Apaf-1 monomers increases the chance
for the intermediate oligomers to contribute to the formation of a complete assembly, it also slows
down the whole process of assembly production. This makes an intermediate speed of Apaf-1
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activation optimum for efficient production of Apaf-1 heptamers in a finite time. From equations
(4), we see that the speed of Apaf-1 activation is proportional to αc. Therefore the region for high
concentration of Apaf-1 heptamers exists along the line αc0 = constant in the parameter space (see
Fig 7). The activation rate of Apaf-1 monomer, α, must be decreased as the amount of cytochrome
c increases to keep the speed of Apaf-1 activation at an intermediate optimum level.
As is discussed above, it is necessary to reduce the speed of Apaf-1 activation under ex-
cessive cytochrome c release to maximizes the accumulation speed of Apaf-1 heptamers in a finite
time. The mechanism regulating the speed of Apaf-1 activation exists in cells. It is reported that
the interaction between cytochrome c and Apaf-1 depends on the ionic strength(Purring et al.,
1999). Cytochrome c and Apaf-1 are positively and negatively charged, respectively. The in vitro
experiment has shown that the concentration of cation in the reaction buffer inhibits the interaction
between cytochrome c and Apaf-1 (Purring-Koch & McLendon, 2000). The alteration of the con-
centration of cytoplasmic cation by calcium flux may regulate the association rate α of interaction
between cytochrome c and Apaf-1. Inhibition of interaction between cytochrome c and Apaf-1 by
calcium may decelerate the speed of Apaf-1 activation.
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Figure 1: Schematic view of the extrinsic and the intrinsic triggering pathway of apoptotic signal
cascade. Either the activation of the caspase-8 and subsequent activation of Bid, or abnormality of
cells, triggers the release of cytochrome c from mitochondria to cytoplasm. Cytoplasmic cytochrome
c binds the Apaf-1 protein. This interaction introduces the conformational change of the Apaf-1,
leading to an activated Apaf-1. Activated Apaf-1 monomer or oligomer can interact with each
other and form a larger oligomer, and this assembly process finally ends up with the production
of heptamer protein complex called apoptosome. Caspase-9 is activated in apoptosome without
cleavage. Activated caspase-9 can cleave and activate the executioner caspase-3. Active complex
of caspase-3 then causes the apoptosis.
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Figure 2: The diagram of oligomerization of Apaf-1. The oligomer composed of i molecules of
Apaf-1 can interact with oligomer composed of j molecules of Apaf-1 only when i+ j is less than
7, which results in a larger oligomer composed of i+ j molecules of Apaf-1.
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Figure 3: The time course of the concentrations of the each oligomers. The apoptotic signal is
added to the cell at time τ = 0, and cytochrome c of the amount c0 is released in cytoplasm at
the same time. Inactive Apaf-1 designated by Y is consumed by the interaction with cytochrome c
and its concentration decreases. The concentration of intermediate Apaf-1 oligomers increase step
by step. Monomers, dimers and trimers are all consumed for the production of larger oligomers
after they increased once. The concentrations of tetramers and larger oligomers also attain their
peaks one by one, and start declining thereafter. However, their concentrations remains positive
when all reactions are stopped. Parameters: n = 7, c0 = 70.0[µM], y0 = 70.0[µM], α = β =
0.004 [µM−1s−1]. The trajectories are obtained from equations (5) with the rescaled parameter
values C0 = c0/y0 = 1.0 and λ = α/β = 1.0. The time axis is scaled logarithmically.
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Figure 4: The final concentration of Apaf-1 heptamer relative to the one n-th of the initial con-
centration of inactive Apaf-1 (nXn), which represents the conversion efficiency of Apaf-1 heptamer
assembly process. The horizontal axis indicates the ratio of the initial concentration of cytochrome
c to that of Apaf-1. The vertical axis indicates the final concentration of the complete products
composed of different number n of unit molecules.
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Figure 5: The time course of the consumption of inactive Apaf-1. Inactive Apaf-1 is consumed by
its binding to cytochrome c. The speed of the consumption of inactive Apaf-1 depends on the ratio
of the initial concentration of cytochrome c to that of inactive Apaf-1. The speed of the decline of
inactive Apaf-1 strongly affects the final concentration of complete product, because all reactions
have to stop when the concentration of small oligomers composed of less than half of n molecules
becomes 0. Dotted line show the case if c0 > y0 (in this plot c0 = 2× y0), inactive Apaf-1 decreases
exponentially. Whereas, solid line show the case if c0 = y0, the concentration of inactive Apaf-1
decreases only geometrically slowly – y(t) is proportional to the reciprocal of time.
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Figure 6: The speed of the apoptotic signal transduction, measured with T50, the time until the
concentration of complete product reaches the half of its final concentration. The reciprocal of T50
represents the speed of the apoptotic signal transduction. T50 decreases with c0/y0 in almost all its
range except when c0 ≈ y0. When c0 = y0, the reaction proceeds geometrically slowly, and hence
T50 has a small local peak around it.
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Figure 7: The contour plot for the concentration of complete Apaf-1 heptamer, x7(t), at time
t = 100.0[s] after the release of cytochrome c, calculated from equations (4). For a fixed α/β,
there is an optimum c0/y0, indicating that neither too few nor too much release of cytochrome c is
advantageous for the efficiency of complete Apaf-1 heptamer assembly. Likewise, for a fixed c0/y0,
there is an optimum α/β ratio.
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Figure 8: The contour plot for the final concentration X7(∞) of Apaf-1 heptamer in the apoptotic
signal transduction, plotting against α/β and c0/y0, calculated from equations (5). In contrast to
the results for a finite time case (Fig 7), the area for high concentration of complete Apaf-1 heptamer
is restricted in the region near c0/y0 = 1.0. The final concentration monotonically increases with
decreasing α/β. A small α/β implies a slow production of active Apaf-1 monomers, which increases
the conversion efficiency of the Apaf-1 heptamer assembly.
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Figure 9: The time changes of the concentration of complete Apaf-1 heptamer for various γ,
with c0 ≫ y0. When γ is small, the mean relaxation time for the dissociation of intermediate
oligomers is very long, and the complete Apaf-1 heptamer reaches a plateau before substantial
dissociation occurs. The results with nonzero dissociation fail to show any significant difference
from the result without dissociation when γ is sufficiently small. Therefore, for sufficiently small
γ, the approximation that neglects the dissociation of intermediate oligomers can be guaranteed.
Parameters: α = β = 0.004[µM−1s−1].
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